Eesti Farmakoloogia Selts

Year	Period	Submitted	Status
2025	01.07.2025 – 30.06.2026	31.12.2026	Not submitted
2024	01.07.2024 – 30.06.2025	27.01.2026	Valid	PDF
2023	01.07.2023 – 30.06.2024	16.12.2024	Valid	PDF
2022	01.07.2022 – 30.06.2023	27.11.2023	Valid	PDF
2021	01.07.2021 – 30.06.2022	27.11.2023	Valid	PDF
2020	01.07.2020 – 30.06.2021	13.07.2022	Valid	PDF
2019	01.07.2019 – 30.06.2020	16.06.2021	Valid	PDF
2018	01.07.2018 – 30.06.2019	16.12.2019	Valid	PDF
2017	01.07.2017 – 30.06.2018	19.02.2019	Valid	PDF
2016	01.07.2016 – 30.06.2017	29.12.2017	Valid	PDF
2015	01.07.2015 – 30.06.2016	31.12.2016	Valid	PDF
2014	01.07.2014 – 30.06.2015	30.12.2015	Valid	PDF
2013	01.07.2013 – 30.06.2014	22.12.2014	Valid	PDF
2012	01.07.2012 – 30.06.2013	16.12.2013	Valid	PDF
2011	01.07.2011 – 30.06.2012	27.12.2012	Valid	PDF
2010	01.07.2010 – 30.06.2011	30.12.2011	Valid	PDF
2009	01.07.2009 – 30.06.2010	13.05.2011	Valid	PDF
2009	01.07.2009 – 30.06.2010	04.01.2011	Expired	PDF
1997	01.01.1997 – 31.12.1997	-	-
1996	01.01.1996 – 31.12.1996	-	-
1995	01.07.1994 – 31.12.1995	-	-

Unsubmitted declarations

No unsubmitted declarations found

No unsubmitted declarations as of 22.10.2026.

Check company creditworthiness in seconds

Detailed reviews of company financial risks and strengths

3€ /monthGet started

Tax debt Reports Declarations Court decisions–Official announcements1 TTJA decisions–Real estate–.ee domains–Licenses–Regulations21 Public transactions2 Grants2 State aid1 Public procurement–Holdings in companies–Enforcement proceedings Payment orders

Tax data

Period	State taxes	Labour taxes	Taxable turnover	Employees
2020 Q1	0 €	0 €	0 €	0
Total 2020:	0 €	0 €	0 €
2019 Q4	0 €	0 €	0 €	0
2019 Q3	0 €	0 €	0 €	0
2019 Q2	0 €	0 €	0 €	0
2019 Q1	0 €	0 €	0 €	0
Total 2019:	0 €	0 €	0 €
2018 Q4	0 €	0 €	0 €	0
2018 Q3	0 €	0 €	0 €	0
2018 Q2	0 €	0 €	0 €	0
2018 Q1	0 €	0 €	0 €	0
Total 2018:	0 €	0 €	0 €
2017 Q4	0 €	0 €	0 €	0
2017 Q3	0 €	0 €	0 €	0
2017 Q2	0 €	0 €	0 €	0
2017 Q1	0 €	0 €	0 €	0
Total 2017:	0 €	0 €	0 €
2016 Q4	0 €	0 €	0 €	0
2016 Q3	0 €	0 €	0 €−100%	0
2016 Q2	273 €	300 €	448 €	0
Total 2016:	273 €	300 €	448 €
2015 Q4	0 €	0 €	0 €	0
2015 Q3	0 €	0 €	0 €	0
2015 Q2	0 €	0 €	0 €	0
2015 Q1	0 €	0 €	0 €	0
Total 2015:	0 €	0 €	0 €

Revenue by industry

	2017
Business consultancy and other management advice	68 993 €

Tax debts

No tax debt found

No tax debt as of 22.10.2026

Representatives

	Personal ID code
Alar Irs	37307XXXXXX	03.07.1973 (53)	Board member	15.10.2025	-
Külli Jaako	47612XXXXXX	04.12.1976 (49)	Board member	15.10.2025	-
Malle Kuum	48211XXXXXX	05.11.1982 (43)	Board member	15.10.2025	-

20 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

Ultimate beneficial owners

	Personal ID code
Alar Irs	37307XXXXXX	03.07.1973 (53)	Board member(s)	20.12.2024	-
Külli Jaako	47612XXXXXX	04.12.1976 (49)	Board member(s)	20.12.2024	-
Malle Kuum	48211XXXXXX	05.11.1982 (43)	Board member(s)	20.12.2024	-

20 inactive records hidden, extended access to the information portal is required to view history!

3€ /monthGet started

Holdings in companies

No holdings in companies found

Company has no holdings in other companies

2020 Q1

Turnover

Amount: 0 €
Monthly average: 0 €
Per employee: -

Labour taxes

Turnover ratio: -
Tax ratio: -
Monthly average: 0 €
Per employee: -

State taxes

Monthly average: 0 €
Turnover ratio: -

Estimated salary

Gross salary: -
Net salary: -

Aggregate data

Last 5 yrsAll

	2024	2023	2022	2021	2020	2019
Current assets	22 838 €−3,5%	23 672 €−0,1%	23 698 €+2,9%	23 038 €+61,0%	14 309 €−0,9%	14 442 €
Non-current assets	-	-	-	-	-	2 556 €
Total assets	22 838 €−3,5%	23 672 €−0,1%	23 698 €+2,9%	23 038 €+61,0%	14 309 €−0,9%	14 442 €
Short-term liabilities	-	-	-	-	-	105 €
Long-term liabilities	-	-	-	-	-	-
Total liabilities	-	-	-	-	-	105 €
Share or stock capital	-	-	-	-	-	-
Retained earnings	-	-	-	-	-	-
Net profit	-	-	-	-	-	2 191 €
Equity	-	-	-	-	-	2 191 €
Turnover	-	-	-	-	-	68 993 €
Profit margin	-	-	-	-	-	3,2%

Financial ratios

	2021	2020
Profit and cash flow
EBITDA	-	-
Liquidity
Current ratio	-	-
Quick ratio	-	-
Cash ratio	-	-
Efficiency
Days sales outstanding (dso)	-	-
Asset turnover	-	-
Structure
Debt ratio	1,0	1,0
Profitability
Operating margin	-	-
Net profit margin	-	-
Return on assets (roa)	46,7%	-0,2%
Return on equity (roe)	37,9%	-0,2%

Data export

These figures for over 281,000 companies, in one table

Revenue, EBITDA, ROE, ROA and other ratios
Up to five years of reports at once
Excel, CSV or JSON, updated daily

See how it works

To view all financial ratios, you need to subscribe to extended access to the info portal!

3€ /monthGet started

Licences & notices

No licenses and notices found

Company has no active licenses and business activity notices

Regulations


M 20014276 / 18	02.01.2026	Entry – Amendment entry	-	Entered into force02.01.2026
M 20014276 / 17	15.10.2025	Entry – Amendment entry	-	Entered into force15.10.2025
M 20014276 / M6	08.10.2025	Order to remedy deficiencies – Amendment entry	23.10.2025	Deficiencies remedied15.10.2025
M 20014276 / 16	30.07.2025	Entry – Amendment entry	-	Entered into force30.07.2025
M 20014276 / M5	28.07.2025	Public service of order in Official Announcements – Amendment entry	-	Entered into force28.07.2025

Real estate

No real estate found

Company has no real estate

Consumer Disputes Committee decisions

No consumer dispute committee decisions found

Company has not been issued consumer dispute committee decisions

Court decisions

No court decisions found

The company has no court decisions

Official announcements


Notice of delivery of an order from the court’s registration department	28.07.2025	PDF

Public transactions


22.02.2022	sihtasutus Tartu Ülikooli Kliinikum	120 €Received	OPERATING EXPENSESGeneral hospital services
13.12.2021	Majandus- ja Kommunikatsiooniministeerium	18 631,20 €Received	OTHER GRANTSR&D in other economic sectors

Funded projects


Konverents: Rudolf Buchheim 200. New Essays on the Doctrine of Drugs2014-2020.5.01.20-1460	Ettevõtlikkuse kasvatamine, ettevõtluse kasvu soodustamine, ettevõtluskeskkonna arendamineERDF · Ettevõtluse ja Innovatsiooni Sihtasutus	14.01.2020 – 15.12.20212014-2020	26 616 €support 70,0%	26 616 €	Completed
ESN2015 - "ESN Conference on Molecular Mechanisms of Regulation of Nervous System" (Euroopa Neurokeemia Ühingu konverents 2015)3.1.2301.14-0294	Rahvusvaheliste ürituste ja konverentside toetamineERDF · Ettevõtluse ja Innovatsiooni Sihtasutus	01.09.2014 – 30.09.20152007-2013	56 879,63 €	53 482,23 €	Completed

State aid


27.05.2020	Ettevõtluse ja Innovatsiooni SihtasutusAid measure 15459	Regionaalareng (VTA) › MuuGrant	18 631 €	15459/2000083

Public procurement contracts

No public procurement contracts found

The company has no public procurement contracts

.ee domains

No domains found

Company has no valid .ee domains

Enforcement proceedings

No enforcement proceedings found

Company has no active debts with bailiffs

Payment orders

No payment orders found

Company has no court-ordered payment orders

Data comes from public registers.